treatment options for patients with triple-class refractory myeloma: the value of immunotherapy
Published 11 months ago • 82 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
1:33
current & emerging treatments for patients with triple-class refractory multiple myeloma
-
2:05
the management of triple-class refractory myeloma in the absence of immunotherapies
-
1:52
managing patients with triple-class exposed myeloma using combination therapies
-
1:47
treatment options for penta-refractory multiple myeloma
-
0:49
management of patients with penta-class refractory myeloma
-
11:41
multiple myeloma - signs and symptoms, pathophysiology, treatment
-
13:19
using the immune system to fight multiple myeloma
-
3:41
can novel immunotherapies cure multiple myeloma?
-
1:56
treatment selection & sequencing in patients with relapsed, intolerant, or refractory myeloma
-
4:10
treatment-free intervals for patients with myeloma
-
3:10
immunotherapy for the treatment of multiple myeloma
-
0:36
the potential of immunotherapies in the myeloma treatment landscape
-
1:29
managing toxicities associated with immunotherapy in multiple myeloma
-
1:26
emerging monoclonal antibodies for the treatment of multiple myeloma
-
3:40
the mutagenic impact of radiotherapy & chemotherapy in multiple myeloma and lymphoma
-
1:41
innovative treatment strategies for multiple myeloma
-
2:30
a new era of treatment for multiple myeloma
-
1:42
optimal sequencing of immunotherapies to improve outcomes for patients with multiple myeloma
-
1:35
rationale for using immunotherapies in the frontline treatment of multiple myeloma
-
2:11
perspectives on the treatment of patients with r/r multiple myeloma
-
1:54
the future of multiple myeloma treatment